Key result
MitraClip implantation linked to severe infective endocarditis requiring surgical MVR at 5 weeks.
Case Report (n=1)
Infective endocarditis is a severe potential complication after MitraClip implantation that can destroy native valve tissue and necessitate surgical valve replacement.
Answers are grounded in this paper and cite their sources.
Raises caution for post-MitraClip endocarditis requiring surgery; leaves open true incidence and surveillance needs.
Introduction: An increasing number of patients are treated by percutaneous mitral valve repair by the MitraClip device. The device was evaluated in an animal model prior to use in humans. A high infective endocarditis rate (2 out of 21 one pigs during life) was an important finding in this study (Luk et al, Cardiovascular Path 2009). We refer to a female patient with following endocarditis and acute mitral valve insufficiency after MitralClip. Finally the patient had to be treated successfully by surgical mitral valve procedure. Aims: At first the woman suffered from mitral valve incompetence in the clinical state of NYHA III-IV and was primarily treated successfully by MitralClip. Post interventional procedure the NYHA state immediately recovered to NYHA I. Residual permissive mitral valve incompetence I-II° was classified as an excellent result after MitralClip procedure. Five weeks later the patient felt weak, had fever and returned to NYHA IV again. The Echocardiography showed ruptured chordae and adherent material on the clip. No cerebral event has occurred so far. Based on the diagnosis of a mitral valve endocarditis after MitralClip with an acute mitral valve insufficiency urgent surgical procedure was required. The intraoperative findings showed an almost completely destroyed mitral valve. The Mitral Clip device performed perforations in the annulus of mitral valve and chordae were ruptured. Too little left native valve texture was insufficient for any techniques of mitral valve repair. For that reason there had to be a mitral valve replacement with a biological prosthesis. Perioperative course and 1-year follow-up was reported uneventful. Discussion: The risk of infective endocarditis after MitraClip has to be considered. Furthermore the risk of thrombotic adhesion attended by infective process has to be reconsidered. In view of the fact that the MitralClip device is a large foreign body in the hemodynmic centre of the valve, long term data regarding endocarditis and cerebral events have to be evaluated. A surgical repair, that was initially possible with ease, is not very likely after MitraClip endocarditis.
No takes yet. Share an insight, caveat, or question.
Maznikoski et al. (2013) conducted a case report in Infective endocarditis after MitraClip (n=1). MitraClip was evaluated on Infective endocarditis and acute mitral valve insufficiency requiring surgery. A female patient developed severe infective endocarditis and acute mitral valve insufficiency 5 weeks after MitraClip implantation, requiring surgical mitral valve replacement.
Synapse has enriched 10 related papers. Consider them for comparative context: